{
  "docId": "019dd923-622c-750b-8b9a-21918ac10c17",
  "docSlug": "f3db2294dcf9",
  "documentTitle": "Harmony Biosciences (HRMY)",
  "authorId": "58_Scorpion_Capital",
  "authorName": "Scorpion Capital",
  "documentKindSlug": "research-note",
  "documentKindLabel": "Research note",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2023-03-28 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 35,
  "pageCount": 366,
  "prevPage": 34,
  "nextPage": 36,
  "slideType": "villain_critique",
  "function": "name_villain",
  "density": "dense",
  "nDataPoints": 2,
  "notes": "The slide uses a narrative of past misconduct to establish a pattern of behavior for the subject.",
  "elementsJson": [
    "paragraph",
    "screenshot"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9a-21918ac10c17/35",
  "deckHref": "/decks/019dd923-622c-750b-8b9a-21918ac10c17",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9a-21918ac10c17.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9a-21918ac10c17#slide-35",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "Aronin’s actions caused widespread outrage, leading to his expulsion from the board and membership of PhRMA, the top pharma lobbying organization.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-64d0-7099-9ccb-875af248a932",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.45,
        "x": 0.07,
        "y": 0.69
      },
      "kind": "list",
      "text": "Under Fire over Price, Marathon Sells Duchenne Drug Emflaza to PTC",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3518184d-de28-4660-9269-d018b995d2ed",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.45,
        "x": 0.07,
        "y": 0.4
      },
      "kind": "list",
      "text": "CEO Under Fire for $89,000 Drug Has a History of Steep Price Hikes",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3fa1c258-777a-4138-94cb-9dc90a0eb062",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.45,
        "x": 0.07,
        "y": 0.81
      },
      "kind": "list",
      "text": "PhRMA expels 22 members with new R&D rules as it works to burnish its image",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7ac249a8-0cc7-4c53-aaa7-0124528b0077",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.45,
        "x": 0.07,
        "y": 0.52
      },
      "kind": "list",
      "text": "Marathon ‘pauses’ launch of $89,000 muscular dystrophy drug in United States amid pricing outrage",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f2ff2119-aa75-4ef3-aa82-7bb1c339a48b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.28,
        "w": 0.86,
        "x": 0.07,
        "y": 0.07
      },
      "kind": "paragraph",
      "text": "Aronin’s actions caused widespread outrage, leading to his expulsion from the board and membership of PhRMA, the top pharma lobbying organization. Prior to Marathon, Aronin employed the same price-gouging strategy at Ovation Pharmaceuticals, buying old drugs and, per the WSJ, raising “prices of five of the drugs by an average of 1,360%.” The FTC unsuccessfully sued Ovation, with the headline of the press release accusing it of “illegally acquiring drug used to treat premature babies with life-threatening condition” and that “unlawful acquisition resulted in nearly 1,300% price hike.”",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c3cfdeb0-d4e1-4cf7-a3c2-05c788b2a5d7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "“prices of five of the drugs by an average of 1,360%.” — WSJ; “illegally acquiring drug used to treat premature babies with life-threatening condition” — FTC; “unlawful acquisition resulted in nearly 1,300% price hike.” — FTC",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd953-64d0-7099-9ccb-880018792ef9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.5,
        "x": 0.07,
        "y": 0.48
      },
      "kind": "source-note",
      "text": "Sources provided for each headline.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3ae742ed-fbba-4b3b-99ba-76a161e4e454",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.25,
        "x": 0.07,
        "y": 0.36
      },
      "kind": "title",
      "text": "Marathon/Aronin press coverage",
      "attrs": null,
      "subkind": "subtitle",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a1017c08-3787-469a-acad-7fe59a7379c7",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "antagonist-introduction",
      "slug": null,
      "matchId": "948aa9e4-7b4c-428c-b3e4-34362788f341",
      "evidence": "The slide explicitly frames the CEO as a villain by detailing past unethical behavior and industry expulsion.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 50,
      "from": 31,
      "beatId": "2b789ae4-940c-4d3a-9f03-7f2e7e4f46fd",
      "arcName": "Overcoming the Monster",
      "arcSlug": "overcoming-monster",
      "beatName": "The Struggle",
      "beatSlug": null,
      "evidence": "The document presents the struggle of the company's critics and short-sellers to expose the truth",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}